RPRX — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-06

• 1.Approximately 22.8 million RP Holdings Class E Interests with an aggregate fair value of approximately $755.4 million, which are expensed over vesting periods on a straight-line basis of generally five to nine years. As of March 31, 2026, we had $609.8 million of unrecognized compensation expense …

• Our historical results of operations for 2025 have been recast to reflect the adoption of ASU 2025-07 by removing the losses previously recognized on derivative. The comparison of our historical results of operations is as follows (in thousands):

• Provision for changes in expected cash flows from financial royalty assets(197,485)(127,140)(70,345)55.3

• Provision for credit losses on unfunded commitments(3,700)— (3,700)n/a

• Income from financial royalty assets by top products is as follows, in order of contribution to income for the first quarter of 2026 (in thousands):

Text removed vs the prior filing · source: 10-Q · 2025-11-05

• For the Three Months Ended September 30,For the Nine Months Ended September 30,

• Other royalty income and revenues also includes revenues from intangible royalty assets and income from royalties that are recorded at fair value.

• 1.Approximately 22.8 million RP Holdings Class E Interests with an aggregate fair value of approximately $755.4 million which are expensed over vesting periods on a straight-line basis of generally five to nine years.

• The comparison of our historical results of operations is as follows (in thousands):

• For the Three Months Ended September 30,ChangeFor the Nine Months Ended September 30,Change

Text added vs the prior filing · source: 10-Q · 2026-05-06

• A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issue…

Text removed vs the prior filing · source: 10-Q · 2025-11-05

• In accordance with guidance issued by the Securities and Exchange Commission, companies are allowed to exclude acquired businesses from the assessment of internal control over financial reporting during the first year after completion of an acquisition. Accordingly, we expect to exclude the portion …

• A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issue…

Text added vs the prior filing · source: 10-Q · 2026-05-06

• •risks related to the growth and dynamics of the royalty market;

• •uncertainties related to acquiring interests in development-stage biopharmaceutical product candidates;

• •potential strategic acquisitions of operating biopharmaceutical companies;

• •our ability to generate increasing royalty receipts and to achieve attractive returns on our investments, including maintaining attractive internal rates of return and consistent returns on invested capital and returns on invested equity;

• •marketers of products that generate our royalties are outside of our control;

Text removed vs the prior filing · source: 10-Q · 2025-11-05

• •uncertainties related to the acquisition of interests in development-stage biopharmaceutical product candidates and our strategy to add interests in development-stage product candidates to our product portfolio;

• •potential strategic acquisitions of biopharmaceutical companies;

• •marketers of products that generate our royalties are outside of our control and are responsible for development, pursuit of ongoing regulatory approval, commercialization, manufacturing and marketing;

• Biopharmaceutical product sales may be lower than expected due to a number of reasons, including pricing pressures, insufficient demand, product competition, failure of clinical trials, lack of market acceptance, changes in the marketer’s strategic priorities, obsolescence, lack of acceptance by hea…

• Other events that affect the banking industry may adversely affect the banking institutions that hold our cash. Our primary operating accounts significantly exceed the Federal Deposit Insurance Corporation limits. In the event of a bank insolvency or failure, we may be considered a general creditor …

Text added vs the prior filing · source: 10-Q · 2026-05-06

• (2)Maximum shares subject to trading plan consists of up to 214,091 Class A ordinary shares and 100% of the shares that may be issued upon settlement of the EPAs awarded for the first and second quarters of 2026.

• (3)On February 12, 2026, Dr. Urist entered into a Trading Plan, scheduled to commence on May 14, 2026 and end on May 26, 2026, providing for the sale of up to 27,368 Class A ordinary shares. In addition, on March 25, 2026, Dr. Urist entered into a Trading Plan, scheduled to commence on June 24, 2026…